Total Synthesis of Bioactive Marine Meroterpenoids: The Cases of Liphagal and Frondosin B

Mar Drugs. 2018 Mar 31;16(4):115. doi: 10.3390/md16040115.

Abstract

Liphagal and frondosin B are two marine-derived secondary metabolites sharing a very similar polyfused-benzofuran skeleton. The two tetracyclic meroterpenoids were isolated from marine sponges, both featuring a 6-5-7-6 fused ring system. A preliminary bioactive study shows that (+)-liphagal is a selective kinase (PI3K α) inhibitor, while (+)-frondosin B is shown to inhibit the binding of the cytokine interleukin-8 (IL-8) to its receptor, CX-CLR1/2. The unique structures and interesting biological profiles of these two meroterpenoids have attracted considerable attention from synthetic chemists. Herein we summarize the synthetic efforts with respect to (+)-liphagal and (+)-frondosin B during the past two decades.

Keywords: frondosin; liphagal; natural product synthesis; total synthesis.

Publication types

  • Review

MeSH terms

  • Animals
  • Benzofurans / chemistry
  • Chemistry, Pharmaceutical / methods
  • Chemistry, Pharmaceutical / trends
  • Heterocyclic Compounds, 4 or More Rings / chemical synthesis*
  • Heterocyclic Compounds, 4 or More Rings / isolation & purification
  • Heterocyclic Compounds, 4 or More Rings / pharmacology
  • Molecular Structure
  • Phosphoinositide-3 Kinase Inhibitors*
  • Porifera / chemistry*
  • Receptors, Interleukin-8 / antagonists & inhibitors*
  • Stereoisomerism
  • Terpenes / chemical synthesis*
  • Terpenes / isolation & purification
  • Terpenes / pharmacology

Substances

  • Benzofurans
  • Heterocyclic Compounds, 4 or More Rings
  • Phosphoinositide-3 Kinase Inhibitors
  • Receptors, Interleukin-8
  • Terpenes
  • frondosin B
  • liphagal